EA200401334A1 - Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением - Google Patents

Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением

Info

Publication number
EA200401334A1
EA200401334A1 EA200401334A EA200401334A EA200401334A1 EA 200401334 A1 EA200401334 A1 EA 200401334A1 EA 200401334 A EA200401334 A EA 200401334A EA 200401334 A EA200401334 A EA 200401334A EA 200401334 A1 EA200401334 A1 EA 200401334A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
levododopa
carbidope
controlled liberation
liberation
Prior art date
Application number
EA200401334A
Other languages
English (en)
Inventor
Мона Гогия
Раджив Шанкар Матхур
Санджив Сетхи
Original Assignee
Ранбакси Лабораторис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ранбакси Лабораторис Лимитед filed Critical Ранбакси Лабораторис Лимитед
Publication of EA200401334A1 publication Critical patent/EA200401334A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям карбидопы и леводопы с контролируемым высвобождением, содержащим сочетание простых эфиров целлюлозы, в частности гидроксипропилцеллюлозу, с разным молекулярным весом.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401334A 2002-04-11 2003-04-11 Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением EA200401334A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN447DE2002 2002-04-11
PCT/IB2003/001361 WO2003084514A1 (en) 2002-04-11 2003-04-11 Controlled release pharmaceutical compositions of carbidopa and levodopa

Publications (1)

Publication Number Publication Date
EA200401334A1 true EA200401334A1 (ru) 2005-04-28

Family

ID=28687123

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401334A EA200401334A1 (ru) 2002-04-11 2003-04-11 Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением

Country Status (7)

Country Link
US (1) US20060159751A1 (ru)
EP (1) EP1496868A1 (ru)
AU (1) AU2003214551A1 (ru)
BR (1) BR0309113A (ru)
EA (1) EA200401334A1 (ru)
MX (1) MXPA04009906A (ru)
WO (1) WO2003084514A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005946B1 (en) * 2006-04-12 2015-11-18 Nippon Soda Co., Ltd. Method for producing extended release tablet
US20090176736A1 (en) * 2006-04-20 2009-07-09 Katsumi Dohura Pharmaceutical composition for conformational diseases
RU2559083C9 (ru) 2009-05-19 2016-01-20 Неуродерм Лтд Композиции для непрерывного введения ингибиторов допа-декарбоксилазы
CN110123743A (zh) 2010-11-15 2019-08-16 纽罗德姆有限公司 L-多巴、多巴脱羧酶抑制剂、儿茶酚-o-甲基转移酶抑制剂及其组合物的连续施用
WO2013183055A1 (en) 2012-06-05 2013-12-12 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
EP3116475B1 (en) 2014-03-13 2020-11-04 Neuroderm Ltd Dopa decarboxylase inhibitor compositions
US20220071909A1 (en) * 2020-08-26 2022-03-10 Rubicon Research Private Limited Modified release formulations of levodopa
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424235A (en) * 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US6103263A (en) * 1994-11-17 2000-08-15 Andrx Pharmaceuticals, Inc. Delayed pulse release hydrogel matrix tablet
WO2001019349A2 (en) * 1999-09-10 2001-03-22 Ranbaxy Laboratories Limited Extended release formulation of etodolac
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa

Also Published As

Publication number Publication date
AU2003214551A1 (en) 2003-10-20
MXPA04009906A (es) 2004-12-13
WO2003084514A1 (en) 2003-10-16
BR0309113A (pt) 2005-02-01
EP1496868A1 (en) 2005-01-19
US20060159751A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1109996T1 (el) Ανοσογονικη συνθεση
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
EA201000491A1 (ru) Аминометилзамещенные тетрациклиновые соединения
UY27346A1 (es) Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco.
BRPI0519046A2 (pt) composição de xampu
SV2004001473A (es) Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo ref.pc 23132
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
TR201909741T4 (tr) Kolon temizleme bileşimleri.
ATE485331T1 (de) Thiolselektive wasserlösliche polymerderivate
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
EA200500074A1 (ru) Пленочное покрытие для таблеток и каплет
EA200300178A1 (ru) Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
NO20072699L (no) Leppefremhevelsessammensetning
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
IS2858B (is) Lyfjasamsetning sem nær yfir melatónín
EA200601759A1 (ru) Композиции рамиприла
BR0309113A (pt) Composições farmacêuticas de liberação controlada de carbidopa e levodopa e processo para a preparação das mesmas
DE502004003470D1 (de) Wasserlösliche, fluoreszierende perylentetracarbonsäure bisimide